Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma.
Wölffer M, Battke F, Schulze M, Feldhahn M, Flatz L, Martus P, Forschner A. Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma. Cancers (Basel) 2022; 14
08.01.2022
Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma.
08.01.2022
Cancers (Basel) 2022; 14
Wölffer Marcus, Battke Florian, Schulze Martin, Feldhahn Magdalena, Flatz Lukas, Martus Peter, Forschner Andrea
Weiter
